Ireland
--:--IST
Starting soon Not applicable

Clinical Evaluation of the Retention of Fissure Sealants Applied Following Guided Biofilm Therapy and Conventional Polishing

NCT07725133 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-07-20
Last updated
2026-07-24

Condition(s) studied

Pit and Fissure Sealant RetentionDental Caries

Investigational drug(s) / intervention(s)

Device: Guided Biofilm Therapy with erythritolDevice: Conventional Polishing

Device: Guided Biofilm Therapy with erythritol: Permanent first molars assigned to Group 1 will receive occlusal surface cleaning using the AIRFLOW® Prophylaxis Master device (EMS, Switzerland) with AIRFLOW® Plus Powder containing approximately 99% erythritol and a particle size of approximately 14 μm. The powder will be applied for 5 seconds from a distance of approximately 2 mm under suction. The tooth surface will then be etched with 37% phosphoric acid for 15 seconds, followed by the application of Clinpro™ Sealant (3M ESPE, USA), which will be light-cured for 15 seconds.

Device: Conventional Polishing: Permanent first molars assigned to Group 2 will receive occlusal surface cleaning using conventional polishing with a rotary prophylaxis brush. The tooth surface will then be etched with 37% phosphoric acid for 15 seconds, followed by the application of Clinpro™ Sealant (3M ESPE, USA), which will be light-cured for 15 seconds.

Study summary

This randomized split-mouth clinical trial will compare two methods of occlusal surface cleaning before pit and fissure sealant placement in children aged 6-10 years.

In each participant, eligible permanent first molars will receive either erythritol-based Guided Biofilm Therapy or conventional rotary-brush polishing before phosphoric acid etching and placement of the same resin-based sealant. Each child will receive both interventions on opposite sides of the mouth.

The sealants will be followed for up to 36 months to determine whether the surface-cleaning method influences sealant retention and clinical performance. Procedure-related discomfort will also be compared between the two methods.

Eligibility

Sex
ALL
Min age
6 Years
Max age
10 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Children aged 6-10 years presenting to the Department of Pediatric Dentistry, Marmara University Faculty of Dentistry, for routine dental treatment. * Systemically healthy individuals classified as ASA I. * Children who are cooperative and able to maintain communication throughout the clinical procedure. * Presence of at least two comparable permanent first molars with unrestored occlusal surfaces that are either caries-free or have initial lesions limited to the pit and fissure level. Exclusion Criteria: * Individuals with systemic diseases (e.g., diabetes, epilepsy, cardiovascular diseases), classified as ASA II or higher. Individuals who have used antibiotics, anti-inflammatory drugs, or immunosuppressive medications within the past 3 months. * Children who are unable to communicate due to emotional, psychological, or developmental disorders. * Individuals with previously placed pit and fissure sealants on their permanent first molars. * Presence of deep carious lesions, restorations, or structural defects such as molar-incisor hypomineralization (MIH) in the teeth planned for inclusion in the study.

Primary outcome measure(s)

  • Pit and Fissure Sealant Retention Assessed Using the Modified Simonsen Criteria — At 3, 6, 12, 24, and 36 months after sealant placement
    Pit and fissure sealant retention will be clinically assessed at the tooth level using the Modified Simonsen Criteria. Score 0 indicates no sealant loss and no caries; Score 1 indicates partial sealant loss without caries; Score 2 indicates partial sealant loss with caries; Score 3 indicates complete sealant loss without caries; and Score 4 indicates complete sealant loss with caries. A score of 1, 2, 3, or 4 at any follow-up visit will be considered retention failure and achievement of the primary endpoint.

Trial sites (1)

FacilityCityRegionStatus
Marmara University Istanbul Maltepe
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07725133 on ClinicalTrials.gov ↗ ← All trials in Turkey